Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Touchreviews in Endocrinology|June 9, 2025
The Role of Remote Glucose Management Using Real-time Continuous Glucose Monitoring Systems in ICU-hospitalized Patients with COVID-19Georgios Logothetis, Konstantinos Avramidis, Evanthia Konstantaki, et al.
The Open Cardiovascular Medicine Journal|September 22, 2016
Pulse Wave Analysis by Applanation Tonometry for the Measurement of Arterial StiffnessJohn Doupis, Nikolaos Papanas, Alison Cohen, et al.
Advances in Therapy|January 23, 2016
Validation of the Greek Version of the Diabetes Management Self-Efficacy Scale (GR-DMSES)Evaggelia Fappa, Vasiliki Efthymiou, George Landis, et al.
Obesity (Silver Spring, Md.)|September 11, 2010
Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factorsJohn Doupis, Shilpa Rahangdale, Charalambos Gnardellis, et al.
Diabetes Care|May 13, 2010
Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort databaseEdward S Horton, Cheryl Silberman, Keith L Davis, et al.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2009
Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathyJohn Doupis, Thomas E Lyons, Szuhuei Wu, et al.
Hormones (Athens, Greece)|January 5, 2010
Thyroid volume, selenium levels and nutritional habits in a rural region in AlbaniaJohn Doupis, Charalambos Stavrianos, Katerina Saltiki, et al.
Vascular Medicine (London, England)|April 16, 2009
Total serum bilirubin does not affect vascular reactivity in patients with diabetesSusie Yim Yeh, John Doupis, Shilpa Rahangdale, et al.
Obesity (Silver Spring, Md.)|February 6, 2010
Effects of adiposity and 30 days of caloric restriction upon protein metabolism in moderately vs. severely obese womenGregory C Henderson, Daniel Nadeau, Edward S Horton, et al.
Current Medical Research and Opinion|June 18, 2004
Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naïve patients with type 2 diabetesEdward S Horton, James E Foley, Sharon G Shen, et al.
Pageof 13